Nav: Home

Without ancestral gene life on Earth might not have evolved beyond slime

March 03, 2016

Researchers at the University of British Columbia have identified a common ancestral gene that enabled the evolution of advanced life over a billion years ago.

The gene, found in all complex organisms, including plants and animals, encodes for a large group of enzymes known as protein kinases that enabled cells to be larger and to rapidly transfer information from one part to another.

"If the duplications and subsequent mutations of this gene during evolution didn't happen, then life would be completely different today," said Steven Pelech, a professor in Division of Neurology in the UBC Faculty of Medicine. "The most advanced life on our planet would probably still be bacterial slime."

Plants, animals, mushrooms and more all exist because they are made up of eukaryotic cells that are larger and far more complex than bacteria. Inside of these eukaryotic cells are hundreds of organelles that perform diverse functions to keep them living, just as different organs do for the human body.

The new research, published this week in the Journal of Biological Chemistry, identifies the gene that gave rise to protein kinases. On a cellular scale, these highly interactive signaling proteins play a role similar to the neurons in the brain by transferring information throughout the cell by a process known as protein phosphorylation.

This ability to transmit signals from one part of the cell to another not only enabled cells to become more complex internally, but also allowed cells to come together to form systems, paving the way for the evolution of intelligent life.

Research into these enzymes has become very important to medicine. More than 400 human diseases like cancer and diabetes are linked to problems with cell signaling. Disease occurs when a cell gets misinformed or confused. Today about one-third of all pharmaceutical drug development is targeted at protein kinases.

For more than 30 years, researchers have known that most protein kinases came from a common ancestor because their genes are so similar.

"From sequencing the genomes of humans, we knew that about 500 genes for different protein kinases all had similar blueprints," said Pelech, also a researcher at Vancouver Coastal Health Research Institute. "Our new research revealed that the gene probably originated from bacteria for facilitating the synthesis of proteins and then mutated to acquire completely new functions."

The same gene that gave rise to protein kinases also led to the formation of a group of enzymes know as choline and ethanolamine kinases. The choline kinase enzyme is critical for the production of phosphatidylcholine, a major component of the membranes that wrap around eukaryotic cells and their organelles, but is missing from bacteria.

Pelech says that the approach they used to study the evolution of this gene could be adapted to study other important protein families and could eventually lead to the creation of a protein version of the evolutionary tree of life.
-end-


University of British Columbia

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...